Target Interacting Protein Information
Target General Information | Top | ||||
---|---|---|---|---|---|
Target ID | T39855 | Target Info | |||
Target Name | Melanoma differentiation-associated protein 6 (CDKN1A) | ||||
Synonyms | WAF1; SDI1; PIC1; P21(WAF1); P21; Melanoma differentiation associated protein 6; MDA6; MDA-6; Cyclin-dependent kinase inhibitor 1; CIP1; CDK-interacting protein 1; CAP20 | ||||
Target Type | Literature-reported Target | ||||
Gene Name | CDKN1A | ||||
UniProt ID |
Target Interacting Proteins | Top | ||||
---|---|---|---|---|---|
Beta-transducin repeats | [+] 1 Beta-transducin repeats | + | |||
Interacting Protein Name | Denticleless protein homolog (DTL) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | CDT2; DCAF2; L2DTL; RAMP | ||||
Evidence Score (E-score) | 3 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [1] | |||
2 | Affinity Capture-Western | [2] | |||
3 | Reconstituted Complex | [3] | |||
Carbon-nitrogen hydrolases | [+] 1 Carbon-nitrogen hydrolases | + | |||
Interacting Target Name | Histone deacetylase 1 (HDAC1) | Successful Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | RPD3L1; HD1 | ||||
Evidence Score (E-score) | 3 Experimental Evidences | + | |||
1 | Co-localization | [4] | |||
2 | Reconstituted Complex | [5] | |||
3 | Reconstituted Complex | [6] | |||
Cell cycle related proteins | [+] 7 Cell cycle related proteins | + | |||
Interacting Target Name | G1/S-specific cyclin-D1 (CCND1) | Clinical trial Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | PRAD1 oncogene; PRAD1; Cyclin D1; BCL-1 oncogene; BCL-1; BCL1; B-cell lymphoma 1 protein | ||||
Evidence Score (E-score) | 9 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [7] | |||
2 | Affinity Capture-Western | [8] | |||
3 | Affinity Capture-Western | [9] | |||
4 | Affinity Capture-Western | [10] | |||
5 | Affinity Capture-Western | [11] | |||
6 | Reconstituted Complex | [12] | |||
7 | Reconstituted Complex | [6] | |||
8 | Yeast two hybrid | [13] | |||
9 | Yeast two hybrid | [14] | |||
Interacting Target Name | G1/S-specific cyclin-E1 (CCNE1) | Literature-reported Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | G1/S-specific cyclin E; Cyclin E; CCNE | ||||
Evidence Score (E-score) | 9 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [7] | |||
2 | Affinity Capture-Western | [15] | |||
3 | Affinity Capture-Western | [9] | |||
4 | Affinity Capture-Western | [12] | |||
5 | Affinity Capture-Western | [16] | |||
6 | Affinity Capture-Western | [17] | |||
7 | Affinity Capture-Western | [18] | |||
8 | Affinity Capture-Western | [19] | |||
9 | Reconstituted Complex | [12] | |||
Interacting Protein Name | G1/S-specific cyclin-D2 (CCND2) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | KIAK0002; MPPH3 | ||||
Evidence Score (E-score) | 5 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [7] | |||
2 | Affinity Capture-Western | [18] | |||
3 | Affinity Capture-Western | [20] | |||
4 | Yeast two hybrid | [21] | |||
5 | Yeast two hybrid | [14] | |||
Interacting Target Name | Cyclin D (CCND3) | Literature-reported Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | G1/S-specific cyclin-D3 | ||||
Evidence Score (E-score) | 4 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [22] | |||
2 | Affinity Capture-MS | [7] | |||
3 | Yeast two hybrid | [21] | |||
4 | Yeast two hybrid | [14] | |||
Interacting Target Name | Cyclin A2 (CCNA2) | Literature-reported Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Cyclin-A2; Cyclin-A; Cyclin A; CCNA | ||||
Evidence Score (E-score) | 3 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [22] | |||
2 | Affinity Capture-MS | [7] | |||
3 | Affinity Capture-Western | [9] | |||
Interacting Target Name | G1/S-specific cyclin-E2 (CCNE2) | Literature-reported Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | G1/Sspecific cyclinE2 | ||||
Evidence Score (E-score) | 3 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [22] | |||
2 | Affinity Capture-MS | [7] | |||
3 | Yeast two hybrid | [23] | |||
Interacting Protein Name | Cyclin-A1 (CCNA1) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | CT146 | ||||
Evidence Score (E-score) | 3 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [11] | |||
2 | Co-localization | [4] | |||
3 | Reconstituted Complex | [24] | |||
Kinases | [+] 7 Kinases | + | |||
Interacting Target Name | Cyclin-dependent kinase 2 (CDK2) | Clinical trial Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | SIN3-associated protein; Sin3 associated polypeptide; P33 protein kinase; Cell division protein kinase 2; CDKN2 | ||||
Evidence Score (E-score) | 20 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [22] | |||
2 | Affinity Capture-MS | [7] | |||
3 | Affinity Capture-Western | [25] | |||
4 | Affinity Capture-Western | [26] | |||
5 | Affinity Capture-Western | [27] | |||
6 | Affinity Capture-Western | [28] | |||
7 | Affinity Capture-Western | [16] | |||
8 | Affinity Capture-Western | [29] | |||
9 | Affinity Capture-Western | [17] | |||
10 | Affinity Capture-Western | [11] | |||
11 | Affinity Capture-Western | [18] | |||
12 | Affinity Capture-Western | [15] | |||
13 | Affinity Capture-Western | [30] | |||
14 | Affinity Capture-Western | [31] | |||
15 | Affinity Capture-Western | [32] | |||
16 | Affinity Capture-Western | [33] | |||
17 | Affinity Capture-Western | [34] | |||
18 | Reconstituted Complex | [35] | |||
19 | Reconstituted Complex | [12] | |||
20 | Reconstituted Complex | [10] | |||
Interacting Target Name | Cyclin-dependent kinase 4 (CDK4) | Successful Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | PSK-J3; Cell division protein kinase 4 | ||||
Evidence Score (E-score) | 10 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [7] | |||
2 | Affinity Capture-Western | [30] | |||
3 | Affinity Capture-Western | [26] | |||
4 | Affinity Capture-Western | [10] | |||
5 | Affinity Capture-Western | [8] | |||
6 | Affinity Capture-Western | [11] | |||
7 | Affinity Capture-Western | [20] | |||
8 | Affinity Capture-Western | [31] | |||
9 | Reconstituted Complex | [10] | |||
10 | Reconstituted Complex | [12] | |||
Interacting Target Name | RAC-alpha serine/threonine-protein kinase (AKT1) | Successful Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | RAC-PK-alpha; RAC; Proto-oncogene c-Akt; Protein kinase B alpha; Protein kinase B; PKB alpha; PKB | ||||
Evidence Score (E-score) | 3 Experimental Evidences | + | |||
1 | Biochemical Activity | [24] | |||
2 | Co-localization | [4] | |||
3 | Reconstituted Complex | [24] | |||
Interacting Target Name | Cyclin-dependent kinase 6 (CDK6) | Successful Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Serine/threonine-protein kinase PLSTIRE; Serine/threonine protein kinase PLSTIRE; Cell division protein kinase 6; CDKN6 | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [36] | |||
2 | Reconstituted Complex | [37] | |||
Interacting Target Name | Cyclin-dependent kinase 1 (CDK1) | Clinical trial Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | P34CDC2; P34 protein kinase; CDKN1; CDC28A; CDC2 | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [22] | |||
2 | Affinity Capture-Western | [38] | |||
Interacting Target Name | Stress-activated protein kinase JNK1 (JNK1) | Clinical trial Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Stress-activated protein kinase 1c; SAPK1c; SAPK1; PRKM8; Mitogen-activated protein kinase 8; MAPK 8; MAP kinase 8; JNK-46; C-Jun N-terminal kinase 1 | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [30] | |||
2 | Biochemical Activity | [39] | |||
Interacting Target Name | Cyclin-dependent kinase 5 (CDK5) | Patented-recorded Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | TPKII catalytic subunit; Tau protein kinase II catalytic subunit; Serine/threonine-protein kinase PSSALRE; Serine/threonine protein kinase PSSALRE; Proline-directed protein kinase F(A) (PDPK F(A)); Proline-directed protein kinase 33 kDa subunit; PDPK; Cyclin-dependent-like kinase 5; Cyclin-dependent kinase 5 (CDK5); Cell division protein kinase 5; CDKN5 | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [7] | |||
2 | Reconstituted Complex | [35] | |||
Membrane-bounded channels | [+] 1 Membrane-bounded channels | + | |||
Interacting Target Name | G2/mitotic-specific cyclin B1 (CCNB1) | Patented-recorded Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | G2/mitotic-specific cyclin-B1; Cyclin B1; CCNB | ||||
Evidence Score (E-score) | 4 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [7] | |||
2 | Affinity Capture-Western | [38] | |||
3 | Affinity Capture-Western | [9] | |||
4 | Reconstituted Complex | [6] | |||
Nuclear hormone receptors | [+] 1 Nuclear hormone receptors | + | |||
Interacting Target Name | Estrogen receptor (ESR) | Successful Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Oestrogen receptor alpha; Oestrogen receptor; Nuclear receptor subfamily 3 group A member 1; NR3A1; Estrogen receptor alpha; Estradiol receptor; ESR; ER-alpha; ERalpha; ER | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [40] | |||
2 | Reconstituted Complex | [41] | |||
Peptidases | [+] 2 Peptidases | + | |||
Interacting Target Name | Caspase-3 (CASP3) | Clinical trial Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Yama protein; SREBP cleavage activity 1; SCA-1; Protein Yama; Cysteine protease CPP32; CPP-32; CPP32; Caspase 3; CASP-3; Apopain | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Biochemical Activity | [42] | |||
2 | Co-localization | [4] | |||
Interacting Protein Name | Ubiquitin carboxyl-terminal hydrolase 11 (USP11) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | UHX1 | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [7] | |||
2 | Affinity Capture-Western | [33] | |||
Pore-forming toxins | [+] 1 Pore-forming toxins | + | |||
Interacting Target Name | Cellular tumor antigen p53 (TP53) | Clinical trial Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Tumor suppressor p53; Phosphoprotein p53; P53; Antigen NY-CO-13 | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [43] | |||
2 | Co-localization | [44] | |||
Transcription regulators | [+] 1 Transcription regulators | + | |||
Interacting Target Name | CREB-binding protein (CREBBP) | Clinical trial Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | CREBbinding protein; CBP | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [41] | |||
2 | Co-localization | [44] | |||
Ubiquitin related proteins | [+] 1 Ubiquitin related proteins | + | |||
Interacting Target Name | Ubiquitin-protein ligase E3 Mdm2 (MDM2) | Clinical trial Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | RING-type E3 ubiquitin transferase Mdm2; P53-binding protein Mdm2; Oncoprotein Mdm2; MDM2 protein; Hdm2; E3 ubiquitin-protein ligase Mdm2; Double minute 2 protein | ||||
Evidence Score (E-score) | 6 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [45] | |||
2 | Affinity Capture-Western | [46] | |||
3 | Affinity Capture-Western | [47] | |||
4 | Co-localization | [4] | |||
5 | Reconstituted Complex | [46] | |||
6 | Reconstituted Complex | [48] | |||
Other proteins | [+] 8 Other proteins | + | |||
Interacting Target Name | Proliferating cell nuclear antigen (PCNA) | Clinical trial Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Cyclin | ||||
Evidence Score (E-score) | 20 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [22] | |||
2 | Affinity Capture-MS | [7] | |||
3 | Affinity Capture-Western | [49] | |||
4 | Affinity Capture-Western | [26] | |||
5 | Affinity Capture-Western | [28] | |||
6 | Affinity Capture-Western | [9] | |||
7 | Affinity Capture-Western | [50] | |||
8 | Affinity Capture-Western | [38] | |||
9 | Affinity Capture-Western | [34] | |||
10 | Affinity Capture-Western | [51] | |||
11 | Affinity Capture-Western | [52] | |||
12 | Affinity Capture-Western | [53] | |||
13 | Co-crystal Structure | [54] | |||
14 | Co-fractionation | [55] | |||
15 | Co-fractionation | [56] | |||
16 | Co-fractionation | [57] | |||
17 | Reconstituted Complex | [55] | |||
18 | Reconstituted Complex | [6] | |||
19 | Reconstituted Complex | [3] | |||
20 | Reconstituted Complex | [58] | |||
Interacting Target Name | p53-binding protein Mdm4 (MDM4) | Clinical trial Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Protein Mdmx; p53-binding protein Mdm4; Mdm2-like p53-binding protein; Double minute 4 protein | ||||
Evidence Score (E-score) | 4 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [59] | |||
2 | Affinity Capture-Western | [57] | |||
3 | Co-fractionation | [57] | |||
4 | Reconstituted Complex | [57] | |||
Interacting Protein Name | BRCA2 and CDKN1A-interacting protein (BCCIP) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | TOK.1; TOK1 | ||||
Evidence Score (E-score) | 3 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [60] | |||
2 | Reconstituted Complex | [25] | |||
3 | Yeast two hybrid | [25] | |||
Interacting Protein Name | DNA damage-binding protein 1 (DDB1) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | DDBA; UV.DDB1; XAP1; XPCE; XPE; XPE.BF | ||||
Evidence Score (E-score) | 3 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [7] | |||
2 | Affinity Capture-Western | [1] | |||
3 | Affinity Capture-Western | [2] | |||
Interacting Target Name | Poly [ADP-ribose] polymerase 1 (PARP1) | Successful Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Protein poly-ADP-ribosyltransferase PARP1; PPOL; Poly[ADP-ribose] synthetase-1; Poly[ADP-ribose] synthase 1; Poly(ADP-ribose)polymerase-1; PARP-1; NAD(+)Poly [ADP-ribose] polymerase-1 ADP-ribosyltransferase-1; NAD(+) ADP-ribosyltransferase-1; NAD(+) ADP-ribosyltransferase 1; DNA ADP-ribosyltransferase PARP1; ARTD1; ADPRT 1; ADPRT; ADP-ribosyltransferase diphtheria toxin-like 1 | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [61] | |||
2 | Reconstituted Complex | [61] | |||
Interacting Target Name | S-phase kinase-associated protein 2 (SKP2) | Literature-reported Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Skp2; P45skp2; FBXL1; F-box/LRR-repeat protein 1; F-box protein Skp2; Cyclin-A/CDK2-associated protein p45; Cyclin A/CDK2-associated protein p45; Cyclin A/CDK2-associated p45 | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [62] | |||
2 | Co-localization | [4] | |||
Interacting Protein Name | Dedicator of cytokinesis protein 7 (DOCK7) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | EIEE23; ZIR2 | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [7] | |||
2 | Yeast two hybrid | [63] | |||
Interacting Protein Name | Tubulin alpha-1A chain (TUBA1A) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | B.ALPHA.1; LIS3; TUBA3 | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [7] | |||
2 | Yeast two hybrid | [63] |
References | Top | ||||
---|---|---|---|---|---|
REF 1 | PCNA-dependent regulation of p21 ubiquitylation and degradation via the CRL4Cdt2 ubiquitin ligase complex. Genes Dev. 2008 Sep 15;22(18):2496-506. | ||||
REF 2 | CDK inhibitor p21 is degraded by a proliferating cell nuclear antigen-coupled Cul4-DDB1Cdt2 pathway during S phase and after UV irradiation. J Biol Chem. 2008 Oct 24;283(43):29045-52. | ||||
REF 3 | The CRL4Cdt2 ubiquitin ligase mediates the proteolysis of cyclin-dependent kinase inhibitor Xic1 through a direct association with PCNA. Mol Cell Biol. 2010 Sep;30(17):4120-33. | ||||
REF 4 | Using an in situ proximity ligation assay to systematically profile endogenous protein-protein interactions in a pathway network. J Proteome Res. 2014 Dec 5;13(12):5339-46. | ||||
REF 5 | An HDAC1-binding domain within FATS bridges p21 turnover to radiation-induced tumorigenesis. Oncogene. 2010 May 6;29(18):2659-71. | ||||
REF 6 | p21WAF1/CIP1 regulates the p300 sumoylation motif CRD1 through a C-terminal domain independently of cyclin/CDK binding. Cell Cycle. 2005 Aug;4(8):1113-9. | ||||
REF 7 | LGALS3BP regulates centriole biogenesis and centrosome hypertrophy in cancer cells. Nat Commun. 2013;4:1531. | ||||
REF 8 | Yin Yang-1 inhibits vascular smooth muscle cell growth and intimal thickening by repressing p21WAF1/Cip1 transcription and p21WAF1/Cip1-Cdk4-cyclin D1 assembly. Circ Res. 2007 Jul 20;101(2):146-55. | ||||
REF 9 | Cyclin-dependent kinases are inactivated by a combination of p21 and Thr-14/Tyr-15 phosphorylation after UV-induced DNA damage. J Biol Chem. 1996 May 31;271(22):13283-91. | ||||
REF 10 | Tyrosine phosphorylation of the p21 cyclin-dependent kinase inhibitor facilitates the development of proneural glioma. J Biol Chem. 2012 Nov 9;287(46):38523-30. | ||||
REF 11 | Highly potent p21(WAF1)-derived peptide inhibitors of CDK-mediated pRb phosphorylation: delineation and structural insight into their interactions with cyclin A. J Pept Res. 2002 Nov;60(5):257-70. | ||||
REF 12 | Cyclin-binding motifs are essential for the function of p21CIP1. Mol Cell Biol. 1996 Sep;16(9):4673-82. | ||||
REF 13 | Next-generation sequencing to generate interactome datasets. Nat Methods. 2011 Jun;8(6):478-80. | ||||
REF 14 | Pooled-matrix protein interaction screens using Barcode Fusion Genetics. Mol Syst Biol. 2016 Apr 22;12(4):863. | ||||
REF 15 | Expression of p21Waf1/Cip1 and cyclin D1 is increased in butyrate-resistant HeLa cells. J Biol Chem. 2001 Oct 12;276(41):37815-20. | ||||
REF 16 | P21Waf1/Cip1 dysfunction in neuroblastoma: a novel mechanism of attenuating G0-G1 cell cycle arrest. Cancer Res. 2003 Jul 1;63(13):3840-4. | ||||
REF 17 | Expression of NPAT, a novel substrate of cyclin E-CDK2, promotes S-phase entry. Genes Dev. 1998 Feb 15;12(4):456-61. | ||||
REF 18 | Increased p21 expression and complex formation with cyclin E/CDK2 in retinoid-induced pre-B lymphoma cell apoptosis. FEBS Lett. 2006 Jun 26;580(15):3687-93. | ||||
REF 19 | Cyclin E/Cdk2 activity is controlled by different mechanisms in the G0 and G1 phases of the cell cycle. Cell Growth Differ. 1996 Oct;7(10):1283-90. | ||||
REF 20 | The role of cyclin D2 and p21/waf1 in human T-cell leukemia virus type 1 infected cells. Retrovirology. 2004 Apr 13;1:6. | ||||
REF 21 | rec-YnH enables simultaneous many-by-many detection of direct protein-protein and protein-RNA interactions. Nat Commun. 2018 Sep 14;9(1):3747. | ||||
REF 22 | A human interactome in three quantitative dimensions organized by stoichiometries and abundances. Cell. 2015 Oct 22;163(3):712-23. | ||||
REF 23 | Cyclin E2, a novel human G1 cyclin and activating partner of CDK2 and CDK3, is induced by viral oncoproteins. Oncogene. 1998 Nov 26;17(21):2787-98. | ||||
REF 24 | Only Akt1 is required for proliferation, while Akt2 promotes cell cycle exit through p21 binding. Mol Cell Biol. 2006 Nov;26(22):8267-80. | ||||
REF 25 | TOK-1, a novel p21Cip1-binding protein that cooperatively enhances p21-dependent inhibitory activity toward CDK2 kinase. J Biol Chem. 2000 Oct 6;275(40):31145-54. | ||||
REF 26 | Akt-dependent phosphorylation of p21(Cip1) regulates PCNA binding and proliferation of endothelial cells. Mol Cell Biol. 2001 Aug;21(16):5644-57. | ||||
REF 27 | Cleavage of p21Cip1/Waf1 and p27Kip1 mediates apoptosis in endothelial cells through activation of Cdk2: role of a caspase cascade. Mol Cell. 1998 Mar;1(4):553-63. | ||||
REF 28 | Caspase-mediated cleavage of p21Waf1/Cip1 converts cancer cells from growth arrest to undergoing apoptosis. Oncogene. 1999 Feb 4;18(5):1131-8. | ||||
REF 29 | CDK2 is involved in the S-phase lengthening induced by glucocorticoids in normal human lymphocytes. Eur J Cell Biol. 2003 May;82(5):253-61. | ||||
REF 30 | p21(Cip1) up-regulated during histone deacetylase inhibitor-induced CD4(+) T-cell anergy selectively associates with mitogen-activated protein kinases. Immunology. 2010 Apr;129(4):589-99. | ||||
REF 31 | Inhibition of G1 cyclin-dependent kinase activity during growth arrest of human breast carcinoma cells by prostaglandin A2. Mol Cell Biol. 1996 Mar;16(3):762-70. | ||||
REF 32 | C/EBP regulates CRL4(Cdt2)-mediated degradation of p21 in response to UVB-induced DNA damage to control the G1/S checkpoint. Cell Cycle. 2014;13(22):3602-10. | ||||
REF 33 | Deubiquitylation and stabilization of p21 by USP11 is critical for cell-cycle progression and DNA damage responses. Proc Natl Acad Sci U S A. 2018 May 1;115(18):4678-4683. | ||||
REF 34 | S-phase Specific Downregulation of Human O6-Methylguanine DNA Methyltransferase (MGMT) and its Serendipitous Interactions with PCNA and p21cip1 Proteins in Glioma Cells. Neoplasia. 2018 Apr;20(4):305-323. | ||||
REF 35 | Molecular basis for the specificity of p27 toward cyclin-dependent kinases that regulate cell division. J Mol Biol. 2005 Jun 17;349(4):764-73. | ||||
REF 36 | Architecture of the human interactome defines protein communities and disease networks. Nature. 2017 May 25;545(7655):505-509. | ||||
REF 37 | Self-assembling protein microarrays. Science. 2004 Jul 2;305(5680):86-90. | ||||
REF 38 | Involvement of the interaction between p21 and proliferating cell nuclear antigen for the maintenance of G2/M arrest after DNA damage. J Biol Chem. 2001 Nov 16;276(46):42971-7. | ||||
REF 39 | The stress-activated protein kinases p38 alpha and JNK1 stabilize p21(Cip1) by phosphorylation. J Biol Chem. 2002 Aug 16;277(33):29792-802. | ||||
REF 40 | Estrogen receptor-dependent proteasomal degradation of the glucocorticoid receptor is coupled to an increase in mdm2 protein expression. Mol Cell Biol. 2003 Aug;23(16):5867-81. | ||||
REF 41 | p21WAF1/CIP1 selectively controls the transcriptional activity of estrogen receptor alpha. Mol Cell Biol. 2005 Mar;25(6):2419-30. | ||||
REF 42 | Caspase 3 specifically cleaves p21WAF1/CIP1 in the earlier stage of apoptosis in SK-HEP-1 human hepatoma cells. Eur J Biochem. 1998 Oct 1;257(1):242-8. | ||||
REF 43 | Radiation-induced phosphorylation of Chk1 at S345 is associated with p53-dependent cell cycle arrest pathways. Neoplasia. 2002 Mar-Apr;4(2):171-80. | ||||
REF 44 | Acetylation-regulated interaction between p53 and SET reveals a widespread regulatory mode. Nature. 2016 Oct 6;538(7623):118-122. | ||||
REF 45 | MDM2 is a negative regulator of p21WAF1/CIP1, independent of p53. J Biol Chem. 2004 Apr 16;279(16):16000-6. | ||||
REF 46 | MDM2 promotes p21waf1/cip1 proteasomal turnover independently of ubiquitylation. EMBO J. 2003 Dec 1;22(23):6365-77. | ||||
REF 47 | 14-3-3Tau regulates ubiquitin-independent proteasomal degradation of p21, a novel mechanism of p21 downregulation in breast cancer. Mol Cell Biol. 2010 Mar;30(6):1508-27. | ||||
REF 48 | MDM2 promotes proteasomal degradation of p21Waf1 via a conformation change. J Biol Chem. 2010 Jun 11;285(24):18407-14. | ||||
REF 49 | Ubiquitin-independent degradation of cell-cycle inhibitors by the REGgamma proteasome. Mol Cell. 2007 Jun 22;26(6):843-52. | ||||
REF 50 | Inhibition of cell proliferation by the PCNA-binding region of p21 expressed as a GFP miniprotein. Exp Cell Res. 2001 May 1;265(2):234-41. | ||||
REF 51 | p15(PAF), a novel PCNA associated factor with increased expression in tumor tissues. Oncogene. 2001 Jan 25;20(4):484-9. | ||||
REF 52 | Purinergic receptor-mediated rapid depletion of nuclear phosphorylated Akt depends on pleckstrin homology domain leucine-rich repeat phosphatase, calcineurin, protein phosphatase 2A, and PTEN phosphatases. J Biol Chem. 2010 Sep 3;285(36):27900-10. | ||||
REF 53 | Increase of palmitic acid concentration impairs endothelial progenitor cell and bone marrow-derived progenitor cell bioavailability: role of the STAT5/PPAR transcriptional complex. Diabetes. 2013 Apr;62(4):1245-57. | ||||
REF 54 | Structure of the C-terminal region of p21(WAF1/CIP1) complexed with human PCNA. Cell. 1996 Oct 18;87(2):297-306. | ||||
REF 55 | The p21 inhibitor of cyclin-dependent kinases controls DNA replication by interaction with PCNA. Nature. 1994 Jun 16;369(6481):574-8. | ||||
REF 56 | Expression of a novel form of p21Cip1/Waf1 in UV-irradiated and transformed cells. Oncogene. 1998 Mar 12;16(10):1333-43. | ||||
REF 57 | MDMX promotes proteasomal turnover of p21 at G1 and early S phases independently of, but in cooperation with, MDM2. Mol Cell Biol. 2008 Feb;28(4):1218-29. | ||||
REF 58 | Human proliferating cell nuclear antigen, poly(ADP-ribose) polymerase-1, and p21waf1/cip1. A dynamic exchange of partners. J Biol Chem. 2003 Oct 10;278(41):39265-8. | ||||
REF 59 | 14-3-3Gamma inhibition of MDMX-mediated p21 turnover independent of p53. J Biol Chem. 2011 Feb 18;286(7):5136-42. | ||||
REF 60 | Inhibition of G1 to S cell cycle progression by BCCIP beta. Cell Cycle. 2004 Mar;3(3):343-8. | ||||
REF 61 | p21CDKN1A participates in base excision repair by regulating the activity of poly(ADP-ribose) polymerase-1. DNA Repair (Amst). 2010 Jun 4;9(6):627-35. | ||||
REF 62 | Cytoplasmic localization and ubiquitination of p21(Cip1) by reactive oxygen species. Biochem Biophys Res Commun. 2007 Jun 22;358(1):219-25. | ||||
REF 63 | A directed protein interaction network for investigating intracellular signal transduction. Sci Signal. 2011 Sep 6;4(189):rs8. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.